WHO Member States Struggle to Balance Global Health Equity and Patent Rights in Pandemic Response
Original framing: “WHO Member States agree to extend negotiations on Pathogen Access and Benefit Sharing annex” — WHO News
The struggle over patent rights and intellectual property laws in the WHO's Pandemic Agreement has historical precedents in the HIV/AIDS epidemic, where pharmaceutical corporations' refusal to share knowledge and technology exacerbated the crisis. This echoes the broader pattern of pharmaceutical corporations prioritizing profits over people during pandemics.
The WHO's Pandemic Agreement reflects a broader struggle between global health equity and the interests of pharmaceutical corporations.
By neglecting the perspectives of marginalized communities and ignoring the historical context of pharmaceutical corporations' influence on global health policy, the WHO risks perpetuating health inequities and undermining global health equity. To address these issues, the WHO should establish a global patent pool, promote community-led pandemic response initiatives, and reform intellectual property laws to prioritize public health over patent rights. By taking these steps, the WHO can promote global health equity and reduce health inequities during pandemics.